Stocktoria
HeartSciences Inc. HSCS
Nasdaq · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies · website · IPO 2022-06-15
HeartSciences Inc. financials (annual)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $4,350 | $18,600 | $5,150 | $14,373 |
| Gross profit | $2,470 | $12,519 | $2,354 | $6,483 |
| R&D expense | $4.4M | $2.9M | $2.5M | $3.0M |
| SG&A expense | $4.0M | $3.4M | $3.7M | $1.7M |
| Operating income | -$8.4M | -$6.3M | -$6.1M | -$4.7M |
| Interest expense | — | $354,080 | $243,174 | $371,619 |
| Income tax | $0 | — | — | — |
| Net income | -$8.8M | -$6.6M | -$6.4M | -$4.8M |
| EPS (diluted) | $-9.34 | $-18.74 | $-80.00 | $-1.45 |
| Operating cash flow | -$7.4M | -$6.1M | -$5.8M | -$3.6M |
| Free cash flow | -$7.4M | -$6.1M | -$5.8M | -$3.6M |
| Cash & equivalents | $1.1M | $5.8M | $1.7M | $918,260 |
| Inventory | $650,267 | $629,179 | $676,359 | $674,139 |
| Total assets | $4.2M | $9.5M | $3.3M | $2.1M |
| Total liabilities | $4.0M | $2.2M | $3.1M | $8.1M |
| Shareholders' equity | $205,171 | $7.3M | $230,557 | -$6.1M |
Growth · year-over-year · Revenue CAGR -32.9%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | -76.6% | +261.2% | -64.2% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-04-30. Facts plus Stocktoria's own computed scores — not investment advice.